Blueprint Medicines shares owned by Mackenzie Financial
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Mackenzie Financial
from 13F filings
Historical chart of Mackenzie Financial investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Mackenzie Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $413k | 4.5k | 92.24 |
| 2023-09-30 | $217k | 4.5k | 48.53 |
| 2023-06-30 | $281k | 4.5k | 62.91 |
| 2023-03-31 | $201k | 4.5k | 44.99 |
| 2022-09-30 | $382k | 5.8k | 65.91 |
| 2022-06-30 | $214k | 4.2k | 50.53 |
| 2022-03-31 | $214k | 3.3k | 63.90 |
| 2021-12-31 | $341k | 3.2k | 107.23 |
| 2021-09-30 | $843k | 8.2k | 102.82 |
| 2021-06-30 | $583k | 6.6k | 87.99 |
| 2016-06-30 | $482k | 24k | 20.25 |
| 2016-03-31 | $399k | 22k | 18.05 |
| 2015-12-31 | $382k | 15k | 26.34 |